JP2003500407A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003500407A5 JP2003500407A5 JP2000619799A JP2000619799A JP2003500407A5 JP 2003500407 A5 JP2003500407 A5 JP 2003500407A5 JP 2000619799 A JP2000619799 A JP 2000619799A JP 2000619799 A JP2000619799 A JP 2000619799A JP 2003500407 A5 JP2003500407 A5 JP 2003500407A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- indicated above
- reacting
- meaning indicated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 Cc1nc(NC)c2NCN(*)c2n1 Chemical compound Cc1nc(NC)c2NCN(*)c2n1 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9906456A FR2793794B1 (fr) | 1999-05-21 | 1999-05-21 | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| FR99/06456 | 1999-05-21 | ||
| PCT/FR2000/001335 WO2000071543A1 (fr) | 1999-05-21 | 2000-05-18 | Derives de la purine, leur procede de preparation, et compositions pharmaceutiques les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003500407A JP2003500407A (ja) | 2003-01-07 |
| JP2003500407A5 true JP2003500407A5 (https=) | 2007-07-05 |
Family
ID=9545846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000619799A Abandoned JP2003500407A (ja) | 1999-05-21 | 2000-05-18 | プリン誘導体、それらの製造方法及びそれらを含有する製薬組成物 |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7122669B1 (https=) |
| EP (1) | EP1183256B1 (https=) |
| JP (1) | JP2003500407A (https=) |
| KR (1) | KR100707895B1 (https=) |
| CN (1) | CN1298719C (https=) |
| AP (1) | AP1477A (https=) |
| AR (1) | AR035317A1 (https=) |
| AT (1) | ATE370951T1 (https=) |
| AU (1) | AU4764500A (https=) |
| BR (1) | BR0011282A (https=) |
| CA (1) | CA2374714A1 (https=) |
| CZ (1) | CZ20014163A3 (https=) |
| DE (1) | DE60036102T2 (https=) |
| DK (1) | DK1183256T3 (https=) |
| DZ (1) | DZ3166A1 (https=) |
| EA (1) | EA005072B1 (https=) |
| ES (1) | ES2290033T3 (https=) |
| FR (1) | FR2793794B1 (https=) |
| HU (1) | HUP0201649A3 (https=) |
| IL (1) | IL146441A0 (https=) |
| MA (1) | MA26791A1 (https=) |
| MX (1) | MXPA01011834A (https=) |
| NO (1) | NO20015659L (https=) |
| NZ (1) | NZ515556A (https=) |
| PL (1) | PL352293A1 (https=) |
| PT (1) | PT1183256E (https=) |
| SK (1) | SK16722001A3 (https=) |
| TR (1) | TR200103349T2 (https=) |
| TW (1) | TWI284130B (https=) |
| UA (1) | UA68441C2 (https=) |
| WO (1) | WO2000071543A1 (https=) |
| YU (1) | YU86601A (https=) |
| ZA (1) | ZA200109602B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| US6969720B2 (en) | 1999-03-17 | 2005-11-29 | Amr Technology, Inc. | Biaryl substituted purine derivatives as potent antiproliferative agents |
| AU3938802A (en) * | 2000-10-31 | 2002-06-03 | Aventis Pharma Inc | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| US6861524B2 (en) * | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
| US6812232B2 (en) | 2001-09-11 | 2004-11-02 | Amr Technology, Inc. | Heterocycle substituted purine derivatives as potent antiproliferative agents |
| US6667311B2 (en) * | 2001-09-11 | 2003-12-23 | Albany Molecular Research, Inc. | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| EP1578722A4 (en) * | 2001-10-12 | 2006-09-06 | Irm Llc | KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF |
| WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
| FR2851248B1 (fr) * | 2003-02-18 | 2005-04-08 | Aventis Pharma Sa | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| US7951592B2 (en) * | 2003-11-10 | 2011-05-31 | The Scripps Research Institute | Compositions and methods for inducing cell dedifferentiation |
| CA2563123A1 (en) * | 2004-04-02 | 2005-10-20 | Adenosine Therapeutics, Llc | Selective antagonists of a2a adenosine receptors |
| CZ302122B6 (cs) * | 2009-01-28 | 2010-10-20 | Univerzita Palackého v Olomouci | Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující |
| WO2012142029A2 (en) | 2011-04-10 | 2012-10-18 | Florida A&M University | Serms for the treatment of estrogen receptor-mediated disorders |
| EP3134405B1 (en) | 2014-04-25 | 2019-08-28 | Pfizer Inc | Heteroaromatic compounds and their use as dopamine d1 ligands |
| CN114149432B (zh) * | 2016-09-30 | 2024-07-05 | 斯坦福国际研究院 | 用于癌症治疗的双重clk/cdk1抑制剂 |
| CZ308029B6 (cs) * | 2017-03-20 | 2019-11-06 | Univerzita PalackĂ©ho v Olomouci | 2,6-Disubstituované-9-cyklopentyl-9H-puriny, jejich použití jako léčiva a farmaceutické přípravky |
| JP2026500305A (ja) | 2022-12-16 | 2026-01-06 | アストラゼネカ・アクチエボラーグ | ２，６，９三置換プリン |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4008858A1 (de) * | 1990-03-20 | 1991-09-26 | Hoechst Ag | Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel |
| EP0841810B1 (en) * | 1991-12-05 | 2000-06-21 | Texas Instruments Incorporated | Method to improve a video signal |
| CA2084222C (en) * | 1991-12-06 | 2004-04-06 | David R. Borcherding | Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| BR9611157A (pt) * | 1995-11-01 | 1999-03-30 | Novartis Ag | Derivados de purina e processos para sua preparação |
| FR2741881B1 (fr) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
| US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
| AU4920397A (en) * | 1996-10-11 | 1998-05-11 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
| CA2297967A1 (en) * | 1997-08-07 | 1999-02-18 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
-
1999
- 1999-05-21 FR FR9906456A patent/FR2793794B1/fr not_active Expired - Fee Related
-
2000
- 2000-05-09 TW TW089108817A patent/TWI284130B/zh not_active IP Right Cessation
- 2000-05-18 US US09/979,389 patent/US7122669B1/en not_active Expired - Fee Related
- 2000-05-18 EA EA200101224A patent/EA005072B1/ru not_active IP Right Cessation
- 2000-05-18 PT PT00929625T patent/PT1183256E/pt unknown
- 2000-05-18 DK DK00929625T patent/DK1183256T3/da active
- 2000-05-18 SK SK1672-2001A patent/SK16722001A3/sk unknown
- 2000-05-18 TR TR2001/03349T patent/TR200103349T2/xx unknown
- 2000-05-18 HU HU0201649A patent/HUP0201649A3/hu unknown
- 2000-05-18 JP JP2000619799A patent/JP2003500407A/ja not_active Abandoned
- 2000-05-18 PL PL00352293A patent/PL352293A1/xx not_active Application Discontinuation
- 2000-05-18 ES ES00929625T patent/ES2290033T3/es not_active Expired - Lifetime
- 2000-05-18 NZ NZ515556A patent/NZ515556A/en unknown
- 2000-05-18 CZ CZ20014163A patent/CZ20014163A3/cs unknown
- 2000-05-18 DZ DZ003166A patent/DZ3166A1/xx active
- 2000-05-18 CN CNB008106509A patent/CN1298719C/zh not_active Expired - Fee Related
- 2000-05-18 AU AU47645/00A patent/AU4764500A/en not_active Abandoned
- 2000-05-18 YU YU86601A patent/YU86601A/sh unknown
- 2000-05-18 CA CA002374714A patent/CA2374714A1/fr not_active Abandoned
- 2000-05-18 WO PCT/FR2000/001335 patent/WO2000071543A1/fr not_active Ceased
- 2000-05-18 EP EP00929625A patent/EP1183256B1/fr not_active Expired - Lifetime
- 2000-05-18 AT AT00929625T patent/ATE370951T1/de not_active IP Right Cessation
- 2000-05-18 UA UA2001128864A patent/UA68441C2/uk unknown
- 2000-05-18 AP APAP/P/2001/002355A patent/AP1477A/en active
- 2000-05-18 KR KR1020017014800A patent/KR100707895B1/ko not_active Expired - Fee Related
- 2000-05-18 MX MXPA01011834A patent/MXPA01011834A/es active IP Right Grant
- 2000-05-18 BR BR0011282-8A patent/BR0011282A/pt not_active Application Discontinuation
- 2000-05-18 DE DE60036102T patent/DE60036102T2/de not_active Expired - Fee Related
- 2000-05-18 IL IL14644100A patent/IL146441A0/xx unknown
- 2000-05-19 AR ARP000102428A patent/AR035317A1/es not_active Application Discontinuation
-
2001
- 2001-11-15 MA MA26410A patent/MA26791A1/fr unknown
- 2001-11-20 NO NO20015659A patent/NO20015659L/no not_active Application Discontinuation
- 2001-11-21 ZA ZA200109602A patent/ZA200109602B/xx unknown
-
2004
- 2004-12-07 US US11/006,013 patent/US7208598B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003500407A5 (https=) | ||
| EP1840125B1 (fr) | Intermédiaires pour la production de dioxane-2-alkylcarbamates | |
| JP2011046751A (ja) | ヒンバシンアナログの合成 | |
| JP2007505891A5 (https=) | ||
| WO2002002546A1 (en) | EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM | |
| JP2005536484A (ja) | 光学活性（ｒ）−アリールオキシプロピオン酸エステル誘導体の製造方法 | |
| JP5001252B2 (ja) | 光学活性アルコールを製造する方法 | |
| US6914159B1 (en) | Process for preparing sulfamoyl-substituted phenethylamine derivatives | |
| KR100906478B1 (ko) | 호모알렌일 알코올 유도체와 인듐을 이용한 이의 제조방법 | |
| JP4859461B2 (ja) | 光学活性ハロヒドリン誘導体およびそれを用いた光学活性エポキシアルコール誘導体の製造法 | |
| US10364211B1 (en) | Methods and intermediates for synthesizing SK1-I | |
| JP2579532B2 (ja) | アミノアセトニトリル誘導体及びその製造方法 | |
| JP3740783B2 (ja) | ４−（２−アルケニル）−２，５−オキサゾリジンジオン類の製造法 | |
| JP3159860B2 (ja) | ４，５−ジホルミルイミダゾール化合物の合成方法及び新規イミダゾール化合物 | |
| JP2940395B2 (ja) | オキシグルタル酸エステル誘導体の製法 | |
| JP3735662B2 (ja) | ヒドロキシエステル化合物とその製造方法 | |
| HU221164B1 (en) | Method for the preparation of 1,3-oxazolidin 5-carboxylic acid | |
| JP2006124347A (ja) | フェニル２−ピリミジニルケトン類の新規製造方法及びその新規中間体 | |
| JP2002544290A5 (https=) | ||
| JP2922943B2 (ja) | イミダゾリジノン誘導体 | |
| JPH0124782B2 (https=) | ||
| CN102906063B (zh) | 制备异丝氨酸衍生物的方法 | |
| JP6205530B2 (ja) | パクリタキセル及びドセタキセルの側鎖前駆体の製造方法 | |
| US20040138463A1 (en) | Short synthesis of pyridine-based pharmaceutical intermediates | |
| BG107145A (bg) | Метод за селективно n-формилиране на n-хидроксиламини |